The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
0.235
-0.029 (-10.84%)
At close: Nov 14, 2024, 4:00 PM
0.260
+0.025 (10.54%)
After-hours: Nov 14, 2024, 7:58 PM EST
The Oncology Institute Stock Forecast
TOI's stock price has decreased by -90.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for TOI stock has a target of 2.50, which predicts an increase of 962.93% from the current stock price of 0.24.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 26, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for TOI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Strong Buy Initiates $2.5 | Strong Buy | Initiates | $2.5 | +962.93% | Feb 26, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $3 → $2 | Strong Buy | Maintains | $3 → $2 | +750.34% | Jun 16, 2023 |
Guggenheim | Guggenheim | Hold Maintains $6 → $3 | Hold | Maintains | $6 → $3 | +1,175.51% | Mar 20, 2023 |
Guggenheim | Guggenheim | Strong Buy Maintains $7 → $6 | Strong Buy | Maintains | $7 → $6 | +2,451.02% | Nov 11, 2022 |
Jefferies | Jefferies | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +4,151.70% | Aug 15, 2022 |
Financial Forecast
Revenue This Year
418.81M
from 324.24M
Increased by 29.17%
Revenue Next Year
487.63M
from 418.81M
Increased by 16.43%
EPS This Year
-0.42
from -0.92
EPS Next Year
-0.16
from -0.42
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 435.4M | 506.9M |
Avg | 418.8M | 487.6M |
Low | 406.4M | 473.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 34.3% | 21.0% |
Avg | 29.2% | 16.4% |
Low | 25.3% | 13.0% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.44 | -0.17 |
Avg | -0.42 | -0.16 |
Low | -0.41 | -0.16 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.